Patents by Inventor Singh Chandan

Singh Chandan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL DIPEPTIDYL PEPTIDASE IV (DP-IV) COMPOUNDS
    Publication number: 20140045771
    Abstract: The present invention is directed to novel compounds of formula I and pharmaceutically acceptable salts, enantiomers thereof having inhibiting properties of dipeptidyl peptidase IV enzyme (DP-IV inhibitors). The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds along with its composition in the prevention or treatment of diseases associated with DP-IV enzyme.
    Type: Application
    Filed: October 21, 2013
    Publication date: February 13, 2014
    Applicant: Cadila Corporated Campus
    Inventors: Bakulesh Mafatlal Khamar, Singh Chandan, Rajiv Indravadan Modi
  • Dipeptidyl peptidase IV (DP-IV) compounds
    Patent number: 8563517
    Abstract: The present invention is directed to novel compounds of formula I and pharmaceutically acceptable salts, enantiomers thereof having inhibiting properties of dipeptidyl peptidase IV enzyme (DP-IV inhibitors). The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds along with its composition in the prevention or treatment of diseases associated with DP-IV enzyme. wherein, A is defined as R3-R4 wherein R3 and R4 are together or independently defined as peptides having amino acids ranging from 1 to 10, B is chemical bond between peptide and substituted amine, R1, and R2 are as defined in specification.
    Type: Grant
    Filed: September 11, 2009
    Date of Patent: October 22, 2013
    Assignee: Cadila Pharmaceuticals Limited
    Inventors: Bakulesh Mafatlal Khamar, Singh Chandan, Rajiv Indravadan Modi
  • NOVEL DIPEPTIDYL PEPTIDASE IV (DP-IV) COMPOUNDS
    Publication number: 20110183919
    Abstract: The present invention is directed to novel compounds of formula I and pharmaceutically acceptable salts, enantiomers thereof having inhibiting properties of dipeptidyl peptidase IV enzyme (DP-IV inhibitors). The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds along with its composition in the prevention or treatment of diseases associated with DP-IV enzyme.
    Type: Application
    Filed: September 11, 2009
    Publication date: July 28, 2011
    Applicant: CADILA PHARMACEUTICALS LTD.
    Inventors: Bakulesh Mafatlal Khamar, Singh Chandan, Rajiv Indravadan Modi